Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Disposition to Issuer of 34,824 APGE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Apogee Therapeutics, Inc. (APGE) | Disposition to Issuer | 34,824 | n/a |
| Jun 17, 2026 | Zenas BioPharma, Inc. (ZBIO) | Grant/Award | 1,592 | $21.3K |
| Jun 12, 2026 | Apogee Therapeutics, Inc. (APGE) | Grant/Award | 7,657 | n/a |
| May 29, 2026 | PROKIDNEY CORP. (PROK) | Grant/Award | 135,000 | n/a |
| Jun 21, 2025 | Apogee Therapeutics, Inc. (APGE) | Grant/Award | 14,461 | n/a |
| Jun 12, 2025 | Zenas BioPharma, Inc. (ZBIO) | Grant/Award | 150,000 | n/a |
| Jun 2, 2025 | PROKIDNEY CORP. (PROK) | Grant/Award | 125,862 | n/a |
| Dec 18, 2024 | Zenas BioPharma, Inc. (ZBIO) | Grant/Award | 8,125 | n/a |
| Sep 17, 2024 | Zenas BioPharma, Inc. (ZBIO) | Grant/Award | 155,000 | n/a |
| Sep 5, 2024 | PROKIDNEY CORP. (PROK) | Grant/Award | 9,535 | n/a |